Influence of beta-galactose-specific mitochondrial lectins from prostate hyperplasic tissue on mitochondrial properties

References

• Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366–81.
   PubMed Web of Science ®Google Scholar
• Chrisofos M, Papatsoris AG, Lazaris A, Deliveliotis C. Precursor lesions of prostate cancer. Crit Rev Clin Lab Sci 2007;44:243–70.
   PubMed Web of Science ®Google Scholar
• De Marzo AM, Meeker AK, Zha Sh, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG. Human prostate cancer precursors and pathobiology. Urology 2003;62(Suppl 5A):55–62.
   PubMedGoogle Scholar
• Joshua AM, Evans A, van der Kwast T, Zielenska M, Meeker AK, Chinnaiyan A, Squire JA. Prostatic preneoplasia and beyond. Biochim Biophys Acta 2008;1785:156–81
   PubMedGoogle Scholar
• Taylor BS, Pal M, Yu J, Laxman Bh, Kalyana-Sundaram Sh, Zhao R, Menon A, Wei JT, Nesvizhskii AI, Ghosh D, Omenn GS, Lubman DM, Chinnaiyan AM, Sreekumar A. Humoral response profiling reveals pathways to prostate cancer progression. Mol Cell Proteomics 2008;7:600–11.
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Galectins, galactoside-binding mammalian lectins: Clinical application of multi-functional proteins. Acta Med Okayama 2001;55:11–7.
   PubMed Web of Science ®Google Scholar
• Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005;5:29–41.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer 2005;92:1188–92.
   PubMed Web of Science ®Google Scholar
• Hsu DK, Yang RY, Liu FT. Galectins in apoptosis. Methods Enzymol 2006;417:256–73.
   PubMedGoogle Scholar
• Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 2008;10:e17.
   PubMedGoogle Scholar
• Fukumori T, Oka N, Takenaka Y, Nangia-Makker P, Elsamman E, Kasai T, Shono M, Kanayama H, Ellerhorst J, Lotan R, Raz A. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res 2006;66:3114–9.
   Google Scholar
• Kierszenbaum A, Rivkin E, Chang P, Tres L, Olsson C. Galactosyl receptor, a cell surface c-type lectin of normal and tumoral prostate epithelial cells with binding affinity to endothelial cells. Prostate 2000;43:175–83.
   PubMedGoogle Scholar
• van den Brule FA, Waltregvy D, Liu FT, Castronovo V. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 2000;89:361–7.
   PubMed Web of Science ®Google Scholar
• Timoshenko AV, Kayser K, Drings P, Kolb G, Havemann K, Gabius HJ. Modulation of lectin-triggered superoxide release from neutrophils of tumor patients with and without chemotherapy. Anticancer Res 1993;13:1789–92.
   PubMed Web of Science ®Google Scholar
• Elola MT, Fink NE. Different galectins can stimulate superoxide production in human neutrophils. E-Lectin J: Lectins Biol Biochem Clin Biochem 2000;13:154–9.
   Google Scholar
• Kvitsinadze N, Kapanadze E, Tsinadze N, Davitashvili E, Solomonia R, Aleksidze N. Influence of galactose-specific lectin isolated from coriander on the lipid peroxidation in the liver cells and erythrocytes. Bull Georg Acad Sci 2003;167:521–3.
   Google Scholar
• Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neuroch 2002;80:760–87.
   Google Scholar
• Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008;68:1777–85.
   PubMed Web of Science ®Google Scholar
• Sikka SC. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemo-prevention, a mechanistic approach. Curr Med Chem 2003;10:2679–92.
   PubMed Web of Science ®Google Scholar
• Scibior-Bentkowska D, Czeczot H. Cancer cells and oxidative stress. Postepy Hig Med Dosw 2009;63:58–72.
   Web of Science ®Google Scholar
• Kvitsinadze N, Megrelishvili I, Davitashvili E, Solomonia R, Aleksidze N, Karazanashvili G. Modulatory effect of zinc on lipid peroxidation in mitochondria and microsoms of a human prostate tissue during various pathologies. Proc Georg Acad Sci Biol Ser A 2006;32:319–23.
   Google Scholar
• Johnson MI, Robinson MC, Marsh C, Robson N, Neal DE, Hamdy FC. Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation. Prostate 1998;37:223–9.
   PubMed Web of Science ®Google Scholar
• Waterhouse NJ, Ricci JE, Green DR. And all of a sudden it's over: mitochondrial outer-membrane permeabilization in apoptosis. Biochimie 2002;84:113–21.
   PubMed Web of Science ®Google Scholar
• Tadrous JP. Diagnostic criteria handbook in histopathology. A surgical pathology Vade Mecum. John Wiley&Sons, 2007. pp. 422.
   Google Scholar
• Davitashvili E, Kapanadze E, Kachlishvili E, Khardzaini T, Elisahvili V. Evaluation of higher basidiomycetes mushroom lectin activity in submerged and solid-state fermentation of agro-industrial residues. Int J Medicin Mushrooms 2008;10:171–9.
   Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121–6.
   PubMed Web of Science ®Google Scholar
• Sharpe MA, Cooper CE. Interaction of peroxynitrite with mitochondrial cytochrome oxidase. J Biol Chem 1998;273:30961–72.
   PubMed Web of Science ®Google Scholar
• Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000;29:222–30.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J. Nutritional aspects of prostate cancer: a review. Can J Urol 2000;7:927–35.
   PubMedGoogle Scholar